98%
921
2 minutes
20
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease resulting from loss-of-function pathogenic variants in ADA2 gene, which might resemble polyarteritis nodosa (PAN). The authors present two pediatric cases of ADA2 deficiency with phenotypic manifestations of PAN, including an unusual presentation with spinal cord ischemia. Also described is an assessment of ADA2 activity and gene expression profiling with description of a previously unreported homozygous variant, c.1226C > A (p.(Pro409His)), detected in a patient with consanguineous parents, confirmed by near-absent ADA2 plasma enzymatic activity. The authors suggest to first obtain enzymatic activity, whenever DADA2 is suspected, before proceeding to genetic testing, due to its excellent cost-effective results. Moreover, physicians must be aware of this monogenic disorder, especially in the case of early-onset PAN-like manifestations, having a family member with similar manifestations or having consanguineous parents suggesting an autosomal recessive inheritance pattern. Given the multi-organ involvement, recognizing the diverse manifestations is a crucial step towards timely diagnosis and management of this potentially fatal but often treatable syndrome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10067-020-05210-4 | DOI Listing |
Microbiol Spectr
September 2025
Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
is the leading cause of fungal meningitis in humans and a major source of mortality in people living with HIV. Infection starts in the lungs and results in meningoencephalitis after dissemination via the bloodstream. Alveolar macrophages are the first immune cells to encounter the infection and are usually capable of clearing it.
View Article and Find Full Text PDFWorld J Clin Cases
August 2025
Department of Plastic Surgery, Zhongshan People's Hospital, Zhongshan 528400, Guangdong Province, China.
This editorial underscores the importance of Maranhão 's study, which investigates pleural adenosine deaminase (P-ADA) as a biomarker for inflammatory pleural effusions. Despite advances in imaging, distinguishing between inflammatory and non-inflammatory causes of pleural effusion remains a diagnostic challenge. The authors conducted a rigorous retrospective cohort analysis of 157 patients (124 with inflammatory exudates and 33 with non-inflammatory transudates), establishing a robust cutoff value of P-ADA ≥ 9.
View Article and Find Full Text PDFHemasphere
June 2025
Department of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.
Congenital neutropenia (CN) comprises a heterogeneous group of rare genetic disorders. While some CN cases present only with neutropenia, others present with additional extra-hematological manifestations. The most common cause of CN is variants in ; however, approximately 30 other genes have been implicated.
View Article and Find Full Text PDFPediatr Rheumatol Online J
May 2025
Rheumatology and Autoinflammatory diseases, IRCCS Istituto Giannina Gaslini, Largo Gaslini 5, Genoa, 16147, Italy.
Background: Deficiency of adenosine deaminase 2 (DADA2) is a rare monogenic autoinflammatory disease mainly characterized by the presence of systemic inflammation and vascular manifestations such as vasculitis and early-onset stroke. Raynaud's phenomenon (RP) can occur in up to 22% of DADA2 patients. The aim of this work was to investigate the microvascular status of DADA2 patients by the mean of nailfold videocapillaroscopy (NVC) comparing them with adequate healthy controls (HC) and primary RP patients.
View Article and Find Full Text PDFYakugaku Zasshi
May 2025
Faculty of Pharmaceutical Sciences, Hokkaido University of Science.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive genetic disorder caused by loss-of-function mutations in the gene encoding adenosine deaminase (ADA) 2. This enzyme catalyzes the deamination reaction of adenosine/2'-deoxyadenosine to inosine/2'-deoxyinosine. DADA2 exhibits a complex clinical presentation, with systemic vasculitis with stroke, bone marrow failure, and immunodeficiency as the major pathologies.
View Article and Find Full Text PDF